Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
05/2010
05/18/2010US7718698 Adding fatty acid ester, a fatty acid amide, a free fatty acid or a hydrocarbon, to a mixture of a fat or an oil, being edible or for use in cosmetics; stripping and separating the environmental pollutant present in the fat or oil
05/18/2010US7718670 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; reaction with organometallic derivative
05/18/2010US7718599 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases
05/18/2010US7718387 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
05/18/2010US7718376 Identification and isolation of somatic stem cells and uses thereof
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010CA2430508C Condensed purine derivatives as a1 adenosine receptor antagonists
05/18/2010CA2288709C Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
05/18/2010CA2121698C Synthesis of human procollagens and collagens in recombinant dna systems
05/14/2010WO2010054397A2 N-cadherin: target for cancer diagnosis and therapy
05/14/2010WO2010053199A1 Pharmaceutical composition for treating prostate cancer, and method for treating prostate cancer
05/14/2010WO2010053120A1 Carbamate compound or salt thereof
05/14/2010WO2010053068A1 Novel useful therapeutic agent for lower urinary tract symptom
05/14/2010WO2010052873A1 Dihydrochloride of indazole derivative
05/14/2010WO2010052329A1 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them
05/14/2010WO2010052192A1 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hgl-msc), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
05/14/2010WO2010052027A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease
05/14/2010CA2743216A1 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them
05/14/2010CA2743133A1 N-cadherin: target for cancer diagnosis and therapy
05/14/2010CA2742910A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease
05/14/2010CA2741500A1 Carbamate compound or salt thereof
05/13/2010US20100120865 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions
05/13/2010US20100120807 Compounds and compositions as modulators of gpr119 activity
05/13/2010US20100120762 Triazine derivatives as inhibitors of phosphodiesterases
05/13/2010US20100120702 Solid preparation for dialysis
05/13/2010US20100120015 Method of collecting placental stem cells
05/13/2010US20100119607 Bioenhanced compositions
05/12/2010EP2184296A1 Fibroblast growth factor (fgf23) and methods for use
05/12/2010EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators
05/12/2010EP2183239A1 Sulfonamides as trpm8 modulators
05/12/2010EP1519933B1 Quinuclidine amide derivatives
05/12/2010CN201453685U Enteric-coated capsule of piperazine ferulate
05/12/2010CN201453684U Enteric-coated capsule of sodium ferulate
05/12/2010CN1947757B Leave of glutinous rehmannia extractive, its preparation method and use, medicines prepared with said extractives
05/12/2010CN1944647B Dopamine receptor new sub-type D5B gene and coded protein and use
05/12/2010CN1903265B Traditional Chinese medicine composition for treating nycturia and its preparing method
05/12/2010CN1895241B Composition of long-acting oral pills of Yansuan Tanshuluoxin and its production method
05/12/2010CN1879756B Quality control method of kidney-replenishing blood-nourishing soft capsule
05/12/2010CN1853687B Use of safflower composition for preparing medicine for treating urinary tract infection
05/12/2010CN1850129B Medicine preparation for preventing and treating heart brain and kidney blood vessel diseases
05/12/2010CN1806576B Method for preparing kidney-replenishing fatigue-alleviating yoghourt with micron antler powder, gadol powder, bee pollen, cactus powder and dodder powder
05/12/2010CN1736371B Selective androgen receptor modulators and methods of use thereof
05/12/2010CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby
05/12/2010CN1617715B Treating muscle wasting with selective androgen receptor modulators
05/12/2010CN1466451B Ion-strength independent sustained release pharmacetuical formulation
05/12/2010CN101704856A 5-alpha reductase inhibitor-nettle diffractive cyclolignan anthocyanin C, preparation method and application thereof
05/12/2010CN101703746A Medicinal composition for treating prostatitis and preparation method thereof
05/12/2010CN101703735A Chinese medicinal preparation for treating ureteral calculus
05/12/2010CN101703733A Medicament for treating tumor-like diseases
05/12/2010CN101703714A Chinese medicinal medicament for treating acute glomerulonephritis
05/12/2010CN101703707A Chinese medicament for treating nephritis hematuria
05/12/2010CN101703706A Chinese medicinal preparation for treating acute nephritis
05/12/2010CN101703671A Chinese medicinal composition for treating kidney-Yang deficiency and preparation method thereof
05/12/2010CN101703640A Chinese medicinal preparation for treating prostatitis
05/12/2010CN101703617A Medicinal composition for treating diabetic nephropathy and preparation method thereof
05/12/2010CN101703613A Preparation method of rehmannia leaf total glycoside extract dry product
05/12/2010CN101703591A Medicament for effectively treating prostate diseases
05/12/2010CN101703560A Salted eucommia bark and concocting method thereof
05/12/2010CN101703555A Health care medicinal liquor for tonifying kidney
05/12/2010CN101703537A Ephedra total polysaccharide extractive and preparation method and medical application thereof
05/12/2010CN101703512A Compound tamsulosin and finasteride controlled release tablet and preparation method
05/12/2010CN101703511A Compound tamsulosin and finasteride sustained release capsule and preparation method thereof
05/12/2010CN101703510A Tamsulosin and finasteride compound sustained release tablets and preparation method thereof
05/12/2010CN101703502A Medicament for treating prostatitis
05/12/2010CN101703486A Novel flutamide tablets and method for preparing same
05/12/2010CN101317964B Chinese medicinal composition with spleen-enlivening and kidney-tonifying function, preparation and uses thereof
05/12/2010CN101092405B Derivative of new benzothiadiazines, preparation method and usage
05/12/2010CN101062356B Chinese traditional medicine for treating children's enuresis
05/12/2010CN101032583B Medicine composition and the preparing method and the content testing method
05/12/2010CN101032545B Novel purpose of Chinese traditional medicine homonoia riparia
05/12/2010CN101028336B Medicinal composition containing lamiophlomis and Touhualiao
05/12/2010CN101011484B Medicine for treating urinary system infection disease and preparation method of its capsule
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7713999 Thrombin receptor antagonists
05/11/2010US7713992 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010WO2010050179A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
05/06/2010WO2009057165A8 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithelial regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
05/06/2010US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same
05/06/2010US20100113567 Recombinant VSV For The Treatment of Tumor Cells
05/06/2010US20100113541 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
05/06/2010US20100113540 Azole and Thiazole Derivatives and Their Use
05/06/2010US20100113484 Treating agent of uropathy
05/06/2010US20100113469 Combination therapy for the treatment-of lower urinary tract symptoms
05/06/2010US20100113468 Quinazoline derivatives as kinase inhibitors
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010US20100113361 Anti-ige vaccines
05/06/2010US20100113354 Therapeutic agent comprising vasohibin
05/06/2010US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
05/06/2010US20100112062 Kidney structures and methods of forming the same
05/06/2010US20100111923 Use of alkaline phosphatase in the treatment of reduced renal function
05/06/2010US20100111914 Stem cells from urine and methods for using the same
05/06/2010US20100111898 Conjoint therapy for treating fibrotic diseases
05/06/2010CA2741783A1 Compounds having tafia inhibitory activity
05/05/2010EP2181990A1 Piperidine derivative
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 562